KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Deferred Taxes (2016 - 2023)

Historic Deferred Taxes for Humana (HUM) over the last 15 years, with Q4 2023 value amounting to -$167.0 million.

  • Humana's Deferred Taxes fell 14925.37% to -$167.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$434.0 million, marking a year-over-year decrease of 7222.22%. This contributed to the annual value of -$192.0 million for FY2024, which is 1497.01% down from last year.
  • Per Humana's latest filing, its Deferred Taxes stood at -$167.0 million for Q4 2023, which was down 14925.37% from -$67.0 million recorded in Q4 2022.
  • In the past 5 years, Humana's Deferred Taxes ranged from a high of $198.0 million in Q4 2020 and a low of -$200.0 million during Q3 2022
  • For the 5-year period, Humana's Deferred Taxes averaged around -$6.9 million, with its median value being $3.0 million (2020).
  • Its Deferred Taxes has fluctuated over the past 5 years, first skyrocketed by 12530.12% in 2019, then crashed by 54666.67% in 2022.
  • Humana's Deferred Taxes (Quarter) stood at $141.0 million in 2019, then surged by 40.43% to $198.0 million in 2020, then tumbled by 92.42% to $15.0 million in 2021, then tumbled by 546.67% to -$67.0 million in 2022, then tumbled by 149.25% to -$167.0 million in 2023.
  • Its Deferred Taxes stands at -$167.0 million for Q4 2023, versus -$67.0 million for Q4 2022 and -$200.0 million for Q3 2022.